0001171843-21-008009.txt : 20211116
0001171843-21-008009.hdr.sgml : 20211116
20211116162009
ACCESSION NUMBER: 0001171843-21-008009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211112
FILED AS OF DATE: 20211116
DATE AS OF CHANGE: 20211116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kavuru Vimal
CENTRAL INDEX KEY: 0001697184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35776
FILM NUMBER: 211416371
MAIL ADDRESS:
STREET 1: 11 MAACKA DRIVE
CITY: HOLMDEL
STATE: NJ
ZIP: 07733
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acasti Pharma Inc.
CENTRAL INDEX KEY: 0001444192
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
BUSINESS PHONE: 450-686-4555
MAIL ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
4
1
ownership.xml
X0306
4
2021-11-12
0
0001444192
Acasti Pharma Inc.
ACST
0001697184
Kavuru Vimal
C/O ACASTI PHARMA INC.
3009 BOUL. DE LA CONCORDE EAST SUITE 102
LAVAL
A8
H7T 2B5
QUEBEC, CANADA
1
0
0
0
Stock Options (Right to Buy)
1.63
2021-11-12
4
A
0
42100
0
A
2031-11-12
Class A Common Shares
42100
42100
D
Based on conversion of exercise price of C$2.05 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7959 on the date of grant.
Stock options granted on 11/12/2021 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable with respect to 25% of the shares every three months.
/s/ Jason Comerford, attorney-in fact for Mr.Kavuru
2021-11-16